Skip to main content
Log in

Extracellular and intracellular action of clodronate in osteolytic bone diseases? A hypothesis

  • Review
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Fleisch H (1988) Bisphosphonates: a new class of drugs in diseases of bone and calcium metabolism. In: Handbook of experimental pharmacology, vol 83. Springer-Verlag, Berlin, Heidelberg, pp 441–466

    Google Scholar 

  2. Kanis JA (1991) A new approach to the management of osteolytic bone metastases. Bone 12(suppl 1):S1–S45

    Google Scholar 

  3. Boonekamp PM, Van der Wee-Pals LJA, Van Wijk-van Lennep MML, Thesing CW, Bijvoet OLM (1986) Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix. Bone Miner 1:27–39

    Google Scholar 

  4. Flanagan AM, Chambers TJ (1989) Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone. Bone Miner 6:33–43

    Google Scholar 

  5. Van Rooijen N (1989) The liposome-mediated macrophage ‘suicide’ technique. Minireview. J Immunol Meth 124:1–6

    Google Scholar 

  6. Van Rooijen N, Van Nieuwmegen R, Kamperdijk EWA (1985) Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate. Ultrastructural aspects of elimination of marginal zone macrophages. Virchows Arch B 49:375–383

    Google Scholar 

  7. Van Rooijen N (1991) High and low cytosolic Ca2+-induced macrophage death? Cell Calcium 12:381–384

    Google Scholar 

  8. Van Rooijen N, Poppema A (in press) Efficacy of various water-soluble chelator molecules in the liposome-mediated macrophage “suicide” technique. J Pharmacol Methods

  9. Sillen LG, Martell AE (1964) Stability constants of metal-ion complexes. Special publication no. 17, Chemical Society of London

  10. Sillen LG, Martell AE (1969) Stability constants of metal-ion complexes (suppl 1). Special publication no. 25, Chemical Society of London

  11. Smith RM, Martell AE (1989) Critical stability constants. Plenum Press, New York

    Google Scholar 

  12. Graf E, Mahoney JR, Bryant RG, Eaton JW (1984) Iron-catalyzed hydroxyl radical formation. J Biol Chem 259:3620–3624

    Google Scholar 

  13. Mönkkönen J, Urtti A, Paronen P, Elo HA, Ylitalo P (1989) The uptake of clodronate (dichloromethylene bisphosphonate) by macrophages in vivo and in vitro. Drug Metab Dispos 17:690–693

    Google Scholar 

  14. Fleisch H (1983) Bisphosphonates. mechanism of action and clinical application. In: Peck WA (ed) Bone and mineral research annual 1. Excerpta Medica, Amsterdam, pp 319–357

    Google Scholar 

  15. Van Rooijen N, Kors N (1989) Effects of intracellular diphosphonates on cells of the mononuclear phagocyte system. In vivo effects of liposome encapsulated diphosphonates on different macrophage subpopulations in the spleen. Calcif Tissue Int 45: 153–156

    Google Scholar 

  16. Mönkkönen J, Van Rooijen N, Ylitalo P (1991) Effects of clodronate and pamidronate on splenic and hepatic phagocytic cells of mice. Pharmacol Toxicol 68:284–286

    Google Scholar 

  17. Rowe DJ, Hausmann E (1976) The alteration of osteoclast morphology by diphosphonates in bone organ culture. Calcif Tissue Int 20:53–60

    Google Scholar 

  18. Mönkkönen J, Ylitalo P, Elo HA, Airaksinen MM (1987) Distribution of 14C-clodronate (dichloromethylene bisphosphonate) disodium in mice. Tox Appl Pharmacol 89:287–292

    Google Scholar 

  19. Fontecave M, Pierre JL (1991) Minireview. Iron metabolism: the low-molecular mass iron pool. Biol Metals 4:133–135

    Google Scholar 

  20. Meunier PL, Alexandre C, Edouard C, Mathieu L, Chapuy MC, Bressot C, Vignon E, Trechsel U (1979) Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone. Lancet ii:489–492

    Google Scholar 

  21. Klein G, Martin JB, Satre M (1988) Methylenedisphosphonate, a metabolic poison inDictyostelium discoideum. 31P NMR evidence for accumulation of adenosine (5′-(β,γ-methylenetriphosphate) and diadenosine 5′,5‴-P1,P4-(P2,P3-methylenetetraphosphate). Biochemistry 27:1897–1901

    Google Scholar 

  22. Saito T, Yamaguchi J (1985) 2-Chloroadenosine: a selective lethal effect to mouse macrophages and its mechanism. J Immunol 134:1815–1822

    Google Scholar 

  23. Kanis JA (1987) Clodronate, a new perspective in the treatment of neoplastic bone disease. Bone 8(suppl 1):S1–S90

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Rooijen, N. Extracellular and intracellular action of clodronate in osteolytic bone diseases? A hypothesis. Calcif Tissue Int 52, 407–410 (1993). https://doi.org/10.1007/BF00571326

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00571326

Keywords

Navigation